Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Lowe`s Companies Inc (LOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Lowe`s Companies Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.95 (market cap $4.59B), while Lowe`s Companies Inc trades at $188.8 (market cap $105.96B). The key difference: Lowe`s Companies Inc is far larger — about 23.1× Definium Therapeutics Inc. Common Shares's market cap, and Lowe`s Companies Inc pays a 2.65% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Lowe`s Companies Inc for 98 Days on average.
| DFTX | LOW | |
|---|---|---|
Market Cap | $4.59B | $105.96B |
Volume | 2,103,937 | 4,039,547 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.45 | $287.39 |
52-Week Low | $10.68 | $179.50 |
Typical Hold Time | 0 Days | 98 Days |
Enterprise Value | $3.55B | $144.81B |
Dividend Yield | — | 2.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Lowe's Companies (LOW) is trading at $181.54, down 1.17% on the day, amid a broader bearish technical trend. The stock shows strong fundamentals with a P/E of 15.35 and consistent earnings beats in recent quarters, though revenue has declined from $96.2B in 2022 to $83.7B in 2025. Recent news highlights the company's innovation with drone delivery partnerships, but the home improvement sector faces headwinds from a sluggish housing market.
The outlook for LOW is mixed; analyst consensus is bullish with a $244.09 price target, but near-term risks include economic pressures on housing and high debt levels. The stock presents a value opportunity for long-term investors given its valuation and dividend history, though volatility may persist until sector conditions improve.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Lowe`s Companies Inc
Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →
